Misonix to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29
FARMINGDALE, N.Y., May 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating in the 16th Annual Craig-Hallum Institutional Investor Conference held at the Depot Renaissance Minneapolis Hotel in Minneapolis, Minnesota on Wednesday, May 29, 2019. Misonix management will be available to meet with institutional investors in one-on-one meetings throughout the day at the conference.
The Misonix investor presentation is available in the “Investor Relations” section of the Company’s website at www.misonix.com. If you have questions about Misonix or are interested in conducting a conference call or meeting with management, please contact the Company’s investor relations firm, JCIR, at (212) 835-8500 or via email at firstname.lastname@example.org.
About Misonix, Inc.Misonix, Inc. (NASDAQ: MSON) designs, manufactures and markets ultrasonic medical devices for the precise removal of hard and soft tissue, including bone removal, wound debridement and ultrasonic aspiration. Misonix is focused on leveraging its proprietary ultrasonic technology to become the standard of care in operating rooms and clinics around the world. Misonix’s proprietary ultrasonic medical devices are used in a growing number of medical procedures, including spine surgery, neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. At Misonix, Better Matters to us. That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of ultrasonic surgical products that radically improve patient outcomes. Additional information is available on the Company’s web site at www.misonix.com.
Contact: Joe Dwyer Chief Financial Officer Misonix, Inc. 631-927-9113
Joseph Jaffoni, Norberto Aja, Jennifer NeumanJCIR212-835-8500 or email@example.com